Blue-Chip Index Pulls Back; S&P Brushes Off Fresh Record High

The VIX hit its lowest level in more than a year, however

Digital Content Manager
Mar 16, 2021 at 4:27 PM
facebook twitter linkedin

Stocks careened lower this afternoon, as investors held their breath over the Federal Reserve's economic policy decision tomorrow, with many fearing that interest rates could continue to rise. The Dow snapped its seven-day streak with a 127-point drop, pulling back from all-time highs. Similarly, the S&P 500 also fell from grace, despite earlier setting a new intraday record. The tech-heavy Nasdaq, meanwhile, was the only benchmark able to hold onto modest gains. 

In other news, traders largely brushed off worse-than-expected retail sales data for February, after January data was revised upward to show a 7.6% jump. What's more, Wall Street's "fear gauge," the Cboe Volatility Index (VIX), dropped to its lowest level in more than a year.

Continue reading for more on today's market, including:

  • Bull signal says don't sweat this gambling stock's pullback. 
  • Walgreens stock under pressure amid opioid lawsuit.
  • Plus, beauty retailer slammed with downgrade; unpacking Sundial Growers' joint venture; AbbVie stock higher on sale talks.

The Dow Jones Industrial Average (DJI - 32,825.95) fell 127.5 points, or 0.4% for the day. Amgen (AMGN) led the Dow components with a 1.9% rise, while Boeing (BA) paced the laggards, falling 3.9%.

Meanwhile, the S&P 500 Index (SPX - 3,962.71) dropped 6.2 points, or 0.2% for the day. The Nasdaq Composite (IXIC - 13,471.57) added 11.9 points, or 0.09% for the day.

Lastly, the Cboe Volatility Index (VIX - 19.79) fell 0.2 point, or 1.2% for the day.

 Closing Summary 0316

Nyse nasdaq 0316

  1. Secretary of State Antony Blinken slammed China’s use of “coercion and aggression” and warned that the U.S. will push back if necessary. (CNBC)
  2. Europe's drug regulator reiterated there was “no indication” AstraZeneca’s (AZN) Covid-19 vaccine causes blood clots, amid additional suspensions. (MarketWatch)
  3. A hefty Guggenheim downgrade sent this beauty retailer skidding.
  4. Here is what to make of Sundial stock ahead of its big joint venture.
  5. AbbVie stock was higher after talks to sell a $5 billion drug portfolio.  

Earnings 0316


Oil Extends Losses; Gold Notches Two-Week High

Oil prices registered their third-consecutive loss on Tuesday, as investors anticipated a rise in crude supplies for the fourth-straight week, in the aftermath of the Texas winter storms. Specifically, the Energy Information Administration (EIA) predicted a 400,000 barrel increase for the week ending on March 12. As a result, April-dated crude fell 59 cents, or 0.9%, to settle at $64.80 per barrel.

Gold prices notched their highest level in two weeks, however. The yellow metal got a boost from the anticipation surrounding the upcoming Fed decision. The commodity also benefitted from new data that showed retail sales and industrial production declining for February. In turn, April-dated gold added $1.70, or 0.1%, to settle at $1,730.90 an ounce.  


Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

Schaeffer's Daily Bulletin Offer


Special Offers from Schaeffer's Trading Partners